Association between periodontitis and blood-ocular barrier disruption.

Aqueous flare blood-aqueous-barrier disruption blood-ocular-barrier breakdown blood-retinal-barrier disruption periodontitis

Journal

European journal of ophthalmology
ISSN: 1724-6016
Titre abrégé: Eur J Ophthalmol
Pays: United States
ID NLM: 9110772

Informations de publication

Date de publication:
May 2023
Historique:
medline: 1 5 2023
pubmed: 20 12 2022
entrez: 19 12 2022
Statut: ppublish

Résumé

Periodontitis causes low-grade systemic inflammation e.g., through circulatory periodontal endotoxins, and it has been associated with cardiovascular morbidity and wet age-related macular degeneration. To assess the association between clinical severity of periodontitis and aqueous flare levels in the eyes. Patients with periodontitis (N = 15) who underwent periodontal treatment by a specialized dentist between the years 2020 and 2021 at the Chin and Mouth Disease Unit, Kymenlaakso Central Hospital, Kotka, Finland were enrolled. Aqueous flare levels, a surrogate marker for blood-aqueous and blood-retinal-barrier disruption, were measured using Laser Flare Meter (FM-600, Kowa Company, Ltd., Nagoya, Japan) before and right after the periodontal treatment and at 3 months. The number of teeth, periodontal probing depth (PPD), periodontal pathogens and antimicrobial treatment were recorded. At baseline, aqueous flare levels correlated with the number of clinically-relevant PPD (>5 mm) pockets (R = 0.789, Poor periodontal status was associated with blood-ocular-barrier breakdown. These findings could expand our understanding of the potential mechanisms and therapeutic targets against retinal vascular diseases and systemic comorbidities in patients with periodontitis.

Identifiants

pubmed: 36529928
doi: 10.1177/11206721221146672
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1473-1479

Auteurs

Minna Karesvuo (M)

Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.
Health Services Dental Care, City of Helsinki, Helsinki, Finland.

Sam Häyry (S)

Chin and Mouth Disease Unit, Kymenlaakso Central Hospital, Kotka, Finland.

Petteri Karesvuo (P)

Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.
Department of Ophthalmology, Helsinki University Central Hospital, Helsinki, Finland.

Piotr Kanclerz (P)

Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.
Hygeia Clinic, Gdańsk, Poland.

Raimo Tuuminen (R)

Helsinki Retina Research Group, University of Helsinki, Helsinki, Finland.
Department of Ophthalmology, Kymenlaakso Central Hospital, Kotka, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH